rules for prescribing Topamax

If you’re struggling with binge eating disorder (BED), you might be wondering whether you can access treatment without visiting a doctor’s office in person. The short answer is yes—in 2026, telehealth has become a safe, legal, and accessible way to receive evaluation and medication for binge eating disorder across the United States.

This comprehensive guide will walk you through everything you need to know about getting BED medication through telehealth, including which medications are available, how state and federal laws work, what to expect during your virtual visit, and how to ensure you’re receiving quality care.

Understanding Binge Eating Disorder and Treatment Options

Binge Eating Disorder is the most common eating disorder in the United States, characterized by recurring episodes of eating large quantities of food in a short period, accompanied by a sense of loss of control. Unlike bulimia, BED doesn’t involve purging behaviors like vomiting or excessive exercise.

According to DSM-5 criteria, a BED diagnosis requires:

• Eating an unusually large amount of food within a two-hour period
• Feeling out of control during these episodes
• Experiencing these episodes at least once weekly for three months
• Marked distress about the binge eating
• Absence of regular compensatory behaviors (like purging)

While therapy—particularly cognitive behavioral therapy (CBT) and dialectical behavior therapy (DBT)—remains the gold standard for BED treatment, medications can play a supportive role in your recovery journey.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Medications Commonly Prescribed for BED via Telehealth

Two non-controlled medications are frequently prescribed off-label for binge eating disorder through telehealth platforms:

Topiramate (Topamax)

Originally FDA-approved for seizure control and migraine prevention, topiramate has shown promise in reducing binge eating episodes. Research suggests it may help with impulse control and can support weight management efforts as part of comprehensive BED treatment.

Key considerations:

• Starting dose: Usually low, with gradual increases to minimize side effects
• Common side effects: Tingling in hands/feet, cognitive changes (‘brain fog’), changes in taste
• Important warning: Not recommended during pregnancy due to increased risk of birth defects, including cleft palate. Women of childbearing age should use effective contraception
• Discontinuation: Must be tapered gradually under medical supervision to avoid seizure risk

Bupropion (Wellbutrin)

FDA-approved for depression and smoking cessation, bupropion has demonstrated effectiveness in reducing binge frequency in some patients. It works differently than typical antidepressants and doesn’t typically cause weight gain—a concern many BED patients have about psychiatric medications.

Key considerations:

• Contraindication: Do not use if you have a history of bulimia, anorexia nervosa, or seizure disorders, as bupropion significantly increases seizure risk in these populations
• Black Box Warning: Like all antidepressants, carries a warning about increased suicidal thoughts in people under 25—close monitoring is essential when starting treatment
• Alcohol warning: Avoid alcohol consumption, which increases seizure risk
• Monitoring needs: Regular blood pressure checks, especially if combined with other medications

It’s important to understand that while the only FDA-approved medication specifically for BED is lisdexamfetamine (Vyvanse)—a controlled stimulant—most telehealth providers don’t prescribe controlled substances for BED due to stricter regulations and abuse potential. Topiramate and bupropion represent accessible, evidence-based alternatives available through virtual care.

Federal Telehealth Prescribing Rules: What You Need to Know

Understanding the regulatory landscape helps explain why these particular medications are readily available via telehealth while others aren’t.

The Ryan Haight Act and Its Limits

The Ryan Haight Act of 2008 requires an in-person medical evaluation before prescribing controlled substances (Schedule II-V drugs like stimulants, opioids, and benzodiazepines) via telemedicine. However, this law never applied to non-controlled medications like topiramate and bupropion.

During the COVID-19 pandemic, even the controlled substance requirement was temporarily waived. As of January 2026, the DEA has extended these telehealth flexibilities for controlled substances through December 31, 2026, while permanent rules are finalized. But for the non-controlled medications used in BED treatment, there has never been—and continues to be—no federal barrier to telehealth prescribing.

What This Means for You

If you’re seeking topiramate or bupropion for binge eating disorder:

• No federal in-person visit requirement exists
• Your provider must be licensed in your state
• The telehealth evaluation must meet the same standard of care as an in-person visit
• Your provider will create comprehensive medical records, just as they would for an office visit

This regulatory clarity makes telehealth an excellent option for BED treatment, especially for people in rural areas, those with mobility challenges, or anyone who finds the idea of discussing eating disorders face-to-face initially overwhelming.

State-by-State Telehealth Requirements

While federal law creates the foundation, individual states add their own requirements. Here’s what you need to know about telehealth prescribing across different states:

States with No In-Person Requirements

The majority of states—including California, New York, Texas, Florida, Michigan, Wisconsin, Delaware, and South Carolina—have no mandatory in-person visit for non-controlled medication prescriptions via telehealth. As long as the provider conducts an appropriate evaluation (which can be done entirely via video or secure messaging in some states), they can prescribe BED medications.

California is particularly progressive, having passed AB 1503 in 2025, which explicitly allows asynchronous telehealth (online questionnaires, secure messaging) to constitute a ‘good faith exam’ for prescribing when clinically appropriate.

New York finalized rules in May 2025 requiring in-person exams before prescribing controlled substances (preparing for when federal waivers end), but these rules do not apply to non-controlled medications like those used for BED.

States Requiring Periodic In-Person Visits

A handful of states ask that patients receiving ongoing telehealth care be seen in person periodically:

Alabama requires an in-person visit within 12 months if you have more than four telehealth visits for the same condition in a year. However, this visit can be completed by any collaborating provider in a practice, not necessarily your telehealth prescriber.

Georgia requires providers to ‘attempt’ an annual in-person examination for continued telemedicine care, though initial evaluations can be conducted via telehealth if the technology allows for an exam equivalent to in-person.

New Hampshire updated its laws in August 2025 to allow telehealth prescribing even for controlled substances (Schedule II-IV), but requires an in-person follow-up examination within 12 months for continued treatment.

These periodic requirements rarely create barriers to starting treatment and can often be satisfied through a visit with your primary care provider or a local collaborating clinic.

Prescription Monitoring Programs (PMPs)

Many states require prescribers to check the state Prescription Drug Monitoring Program database before prescribing controlled substances. However, since topiramate and bupropion are not controlled, most states don’t mandate PMP checks for these medications.

That said, responsible telehealth providers may still review your medication history to:

• Identify potential drug interactions
• Ensure you’re not already taking similar medications
• Check for contraindicated medications (like MAO inhibitors with bupropion)

This is considered good clinical practice rather than a legal requirement.

Who Can Prescribe BED Medications via Telehealth?

Physicians (MDs and DOs)

Medical doctors and doctors of osteopathy can prescribe these medications in all states via telehealth, provided they’re licensed in your state.

Nurse Practitioners (NPs)

The landscape for nurse practitioners has evolved dramatically. As of 2026, approximately 34 states plus Washington, D.C. grant nurse practitioners Full Practice Authority (FPA), meaning they can evaluate, diagnose, and prescribe medications independently without physician oversight.

States that recently joined the FPA ranks include:

• Michigan (2025, via Public Act 47 of 2023)
• Wisconsin (August 2025, APRN Modernization Act)
• Louisiana and Kansas (2023-2024)

In FPA states like California, New York, or New Hampshire, an NP at a telehealth platform can provide your entire BED care independently.

In states requiring collaborative practice (such as Texas, Florida, Alabama, and Georgia), NPs must work under a formal agreement with a supervising physician. This is typically a behind-the-scenes arrangement that doesn’t affect your care experience—you’ll see the NP, and they’ll prescribe under their collaborative agreement. Both names may appear on your prescription.

Physician Assistants (PAs)

Physician Assistants can prescribe non-controlled medications in all states, though they always work under physician supervision (the level of autonomy varies by state). For BED treatment with topiramate or bupropion, a PA working with a telehealth service can absolutely manage your care, with appropriate physician oversight built into the practice structure.

At Klarity Health, our network includes board-certified physicians, nurse practitioners, and physician assistants—all credentialed to provide mental health and eating disorder treatment in your state. We ensure you’re matched with a provider who has the appropriate licensing and expertise for your specific needs.

What to Expect During Your Telehealth Visit

The Initial Evaluation

A legitimate telehealth evaluation for BED should be comprehensive and thorough—typically 30-45 minutes for an initial consultation. Your provider will:

Assess your eating patterns: Expect detailed questions about:

• Frequency and nature of binge episodes
• Triggers for binge eating
• Emotional state before, during, and after binges
• Impact on daily functioning and quality of life
• Previous attempts to control eating

Review your medical history: Including:

• Current medications and supplements
• Allergies and adverse reactions
• Medical conditions (especially seizure disorders, eating disorder history, cardiovascular issues)
• Mental health history (depression, anxiety, trauma)
• Substance use (alcohol, drugs, tobacco)
• For women: pregnancy status, contraception, and breastfeeding

Conduct a mental health screening:

• Depression and anxiety symptoms
• Suicidal thoughts (especially important given bupropion’s black box warning)
• History of other eating disorders
• Trauma history
• Current stressors

Verify your identity and location: Don’t be surprised when your provider asks to see your ID and confirms your physical location. This isn’t invasive—it’s required by many states to ensure they’re licensed to treat you and to prevent fraud.

Discuss treatment options: A quality provider will explain:

• How the medication works for BED
• That it’s an off-label use (and what that means)
• Expected benefits and realistic timelines
• Potential side effects and how to manage them
• Why therapy should be part of your treatment plan
• Alternative approaches

Safety Screening for Contraindications

Your provider will screen for conditions that would make certain medications unsafe:

For bupropion (Wellbutrin):

• Active or past eating disorder with purging (bulimia, anorexia)—absolute contraindication
• Seizure disorder or conditions that lower seizure threshold
• Current or recent MAO inhibitor use
• Abrupt discontinuation of alcohol or benzodiazepines
• Uncontrolled hypertension

For topiramate (Topamax):

• Pregnancy or planning pregnancy (unless benefits clearly outweigh risks)
• Kidney stones or metabolic acidosis history
• Glaucoma
• Significant cognitive impairment

If you have any of these conditions, your provider will discuss alternative treatments. This isn’t a rejection—it’s responsible medicine prioritizing your safety.

Treatment Planning and Informed Consent

Before prescribing, your provider should:

• Explain the off-label nature of the prescription
• Discuss starting dose and titration schedule
• Set realistic expectations (medications support but don’t cure BED)
• Recommend therapy and nutritional counseling
• Outline the follow-up schedule
• Obtain your informed consent for both telehealth and the specific medication

You’ll sign consent forms documenting that you understand:

• The telehealth format and its limitations
• The medication’s risks and benefits
• Your responsibility to report side effects
• The plan for emergency situations

Prescription and Pharmacy Coordination

Once approved for treatment, your provider will send your prescription electronically to the pharmacy of your choice. You should be able to pick up FDA-approved medication from any regular pharmacy—be cautious of services that want to ship medication directly from their own ‘pharmacy’ without using established channels.

For these non-controlled medications, prescribers can typically authorize refills (often up to 6-12 months’ worth), meaning you won’t need a new prescription every month. However, you’ll still need regular follow-up appointments.

Follow-Up Care and Monitoring

Starting medication for BED isn’t a one-time interaction. Quality telehealth care includes:

Initial Monitoring Phase

Week 2-4 check-in: Assess:

• Medication tolerance
• Emerging side effects
• Any early impact on binge frequency
• Need for dose adjustment

Months 1-3: Monthly appointments to:

• Monitor progress toward goals
• Adjust dosing as needed
• Address side effects
• Reinforce behavioral strategies
• Screen for mood changes or other concerns

Ongoing Maintenance

After the initial phase, many patients transition to:

• Bimonthly or quarterly appointments for stable, well-managed treatment
• As-needed messaging through patient portals for questions
• Annual comprehensive reviews (required in some states like Alabama, Georgia, and New Hampshire)

Klarity Health makes ongoing care convenient with flexible scheduling, same-day appointments when needed, and secure messaging with your care team between visits. Our transparent pricing means you know the cost upfront—whether you’re using insurance or paying cash.

Recognizing Quality Telehealth Services

The telehealth industry grew rapidly during the pandemic, and while this increased access, it also led to some problematic practices. High-profile cases—like the 2024 federal indictment of executives from a telehealth startup for inappropriately prescribing Adderall—have highlighted the need for consumer awareness.

Red Flags to Watch For

Be cautious of services that:

• Promise prescriptions before evaluation
• Conduct superficial assessments (less than 15-20 minutes)
• Don’t ask about contraindications or medication history
• Skip discussing non-medication treatments
• Pressure you to start at high doses
• Operate their own pharmacy (rather than using established pharmacies)
• Make guarantees about specific medications
• Don’t require meaningful follow-up

Green Flags of Reputable Providers

Look for services that:

• Conduct thorough initial evaluations (30+ minutes)
• Ask detailed questions about your medical and psychiatric history
• Verify your identity and location
• Discuss multiple treatment options (medication, therapy, nutrition)
• Explain off-label use and obtain informed consent
• Send prescriptions to regular pharmacies
• Schedule regular follow-up appointments
• Have clear emergency protocols
• Provide transparent pricing
• Are staffed by licensed, credentialed providers in your state

Klarity Health prioritizes patient safety through:

• Comprehensive initial evaluations by experienced mental health providers
• Evidence-based treatment protocols
• Integration of therapy and medication management when appropriate
• Acceptance of most major insurance plans and affordable cash pay options
• Real provider availability—not automated systems
• Transparent pricing with no hidden fees

Insurance Coverage and Cost Considerations

Insurance Coverage for Telehealth

Most insurance plans now cover telehealth mental health visits at the same rate as in-person visits, thanks to parity laws and pandemic-era policy changes that have largely been made permanent.

What’s typically covered:

• Initial psychiatric evaluation
• Medication management appointments
• Follow-up visits
• Some plans cover therapy (CBT, DBT) via telehealth

Check with your insurance about:

• Copays for telehealth vs. in-person visits
• Whether your plan requires in-network providers
• Any prior authorization requirements
• Medication formulary (which drugs are covered, generic vs. brand)

Klarity Health accepts most major insurance plans and can verify your coverage before your first appointment, so you know what to expect.

Cash Pay Options

For those without insurance or with high deductibles, cash pay telehealth can be surprisingly affordable:

Typical cash pay costs:

• Initial evaluation: $150-300
• Follow-up medication management: $75-150 per visit
• Therapy sessions: $100-200

Medication costs (without insurance):

• Generic bupropion: $10-30/month
• Generic topiramate: $15-40/month

Klarity Health offers competitive cash pricing, making quality BED treatment accessible even for those paying out-of-pocket. Our transparent pricing means no surprise bills.

Who May NOT Be Appropriate for Telehealth BED Treatment

While telehealth expands access, it’s not right for everyone. You may need in-person care if you have:

Medical Complexity

• Severe, unstable medical conditions requiring physical examination
• Uncontrolled diabetes, cardiovascular disease, or other conditions needing monitoring
• Recent hospitalization for eating disorder complications
• Syncope (fainting) or other symptoms suggesting serious medical issues

Safety Concerns

• Active suicidal ideation with plan and intent
• Recent suicide attempt
• Severe self-harm behaviors
• Need for intensive level of care (partial hospitalization, residential treatment)

Specific Contraindications

• Pregnancy (for topiramate especially)
• Active substance use disorder requiring specialized treatment
• History of multiple failed medication trials suggesting need for specialist evaluation
• Comorbid conditions requiring controlled substances better managed in person

If your telehealth provider identifies any of these during evaluation, they should refer you to appropriate in-person care. This is good medicine, not rejection. Klarity Health maintains relationships with in-person providers and higher levels of care for referrals when needed.

The Role of Therapy in BED Treatment

While this guide focuses on medication access, it’s crucial to understand that medication alone is rarely sufficient for lasting BED recovery.

Evidence-Based Therapies for BED

Cognitive Behavioral Therapy (CBT): The most studied treatment for BED, CBT helps you:

• Identify triggers for binge eating
• Develop healthier coping strategies
• Challenge distorted thoughts about food, weight, and body image
• Establish regular eating patterns
• Build skills to prevent relapse

Dialectical Behavior Therapy (DBT): Particularly helpful for emotion regulation, DBT teaches:

• Mindfulness skills
• Distress tolerance
• Emotional regulation
• Interpersonal effectiveness

Interpersonal Psychotherapy (IPT): Addresses relationship issues and life transitions that may trigger binge eating.

Combining Medication and Therapy

Research consistently shows that combining medication with therapy produces better outcomes than either alone. Medication may help reduce urges and provide a ‘window’ during which you can more effectively engage in therapy and build new skills.

Many telehealth platforms, including Klarity Health, offer both medication management and therapy services, allowing for coordinated care. Our integrated approach means your therapist and prescriber can collaborate on your treatment plan (with your permission), ensuring all aspects of your care work together.

Recent Regulatory Updates (2025-2026)

Staying informed about regulatory changes helps you understand your rights and options:

Federal Updates

DEA Telehealth Extension (December 2025): The DEA extended COVID-era flexibilities for prescribing controlled substances via telehealth through December 31, 2026, while permanent rules are developed. Though this doesn’t affect non-controlled BED medications, it signals continued federal support for telehealth access.

Pending DEA Final Rule: The DEA is expected to publish permanent telehealth prescribing rules by the end of 2026. These will likely include provisions for a ‘special registration’ allowing qualified providers to prescribe controlled substances via telemedicine under certain conditions.

State-Level Changes

New Hampshire (August 2025): SB 252 explicitly allowed telehealth prescribing of Schedule II-IV controlled substances without an initial in-person visit, with annual in-person follow-up required. This modernization expanded access while maintaining safety guardrails.

California (2025): AB 1503 redefined ‘good faith exam’ to explicitly include asynchronous telehealth, further expanding prescribing flexibility.

New York (May 2025): Finalized rules requiring in-person exams before prescribing controlled substances once federal waivers end, preparing for the post-pandemic regulatory environment while preserving telehealth access for non-controlled medications.

Wisconsin (August 2025): The APRN Modernization Act granted nurse practitioners full practice authority, joining the growing number of states recognizing NPs’ ability to provide independent care.

Michigan (2025): Public Act 47 of 2023’s provisions took full effect, establishing full practice authority for experienced nurse practitioners.

What These Changes Mean for You

The regulatory trend is toward establishing permanent, safe telehealth access while addressing concerns about controlled substance misuse. For BED treatment with non-controlled medications, access remains strong and stable across the country, with many states actively working to reduce barriers.

Taking the Next Step: Getting Started with Telehealth BED Treatment

If you’re ready to explore telehealth treatment for binge eating disorder:

1. Prepare for Your Evaluation

Gather information:

• List of current medications and supplements
• Summary of relevant medical history
• Notes about your binge eating patterns (frequency, triggers, duration)
• Questions about treatment options

Consider your goals:

• What do you hope to achieve from treatment?
• Are you open to therapy in addition to medication?
• What barriers have prevented you from getting help before?

2. Choose a Reputable Provider

Look for platforms that:

• Employ licensed, credentialed providers in your state
• Offer comprehensive evaluations
• Provide integrated care (therapy + medication if needed)
• Accept your insurance or offer transparent cash pricing
• Have positive patient reviews and clear credentials

Klarity Health offers:

• Board-certified providers specializing in eating disorders and mental health
• Same-day and next-day appointments in most states
• Both insurance and cash pay options with transparent pricing
• Integrated medication management and therapy
• Ongoing support through secure messaging and flexible scheduling

3. Be Honest and Thorough

Your provider can only help with what they know. Be candid about:

• The full extent of your binge eating
• Other mental health symptoms
• Substance use
• Medical conditions
• Previous treatment experiences
• Concerns about medication

4. Commit to the Process

Recovery from BED is a journey, not a quick fix. Be prepared to:

• Attend regular follow-up appointments
• Communicate honestly about medication effects
• Engage in therapy if recommended
• Be patient with the process (medication effects can take weeks)
• Work on behavioral changes alongside medication

Conclusion: Accessible, Quality BED Treatment Is Within Reach

Telehealth has transformed access to binge eating disorder treatment. In 2026, you can receive comprehensive, evidence-based care from the privacy of your home—no matter where you live in the United States.

The regulatory framework is now well-established: non-controlled medications like topiramate and bupropion can be legally prescribed via telehealth in all 50 states, with only minor variations in requirements. Federal extensions and state modernization efforts continue to support telehealth access while maintaining appropriate safety standards.

Quality matters more than convenience alone. Choose a provider who conducts thorough evaluations, explains treatment options clearly, integrates therapy with medication when appropriate, and provides ongoing support throughout your recovery journey.

If you’re struggling with binge eating disorder, you don’t have to face it alone—and you don’t have to wait weeks for an in-person appointment. Help is available now, through reputable telehealth services that combine the latest evidence-based treatments with the convenience and privacy of virtual care.

Ready to take the first step? Klarity Health connects you with experienced eating disorder specialists who can evaluate your needs and create a personalized treatment plan—often with same-day appointments. We accept most major insurance plans and offer transparent cash pay pricing, making quality care accessible when you need it most.

Visit Klarity Health today to schedule your confidential evaluation and start your journey toward recovery from binge eating disorder.

Research Currency Statement

Verified as of: January 4, 2026

DEA Rules Status: COVID-19 telehealth prescribing flexibilities remain in effect through December 31, 2026 (fourth extension). No federal in-person requirement exists for non-controlled medications—these were never subject to the Ryan Haight Act restrictions on telemedicine. Controlled substance telehealth rules are temporary and extended through 2026 pending a permanent DEA rule.

States Verified: Researched 10+ key states (AL, CA, DE, FL, GA, NH, NY, TX, MI, WI, SC) with latest information as of late 2025. State board sites and 2025 legislative updates were checked where available.

Sources Newer than 2024: 80%+ of sources are from 2025 (many late-2025) or updated to 2025. Older sources (2024) were used only when confirmed still accurate by newer references.

Flagged for Follow-Up: Alabama and South Carolina NP scope changes (legislation was discussed in 2025 but final status unclear—assume no full independence yet pending confirmation). Monitor DEA’s pending final rule on telehealth prescribing (expected by end of 2026). Verify any temporary state waivers for expiration/extension beyond 2025.

Citations

1. U.S. Department of Health and Human Services. (2026, January). DEA extends telemedicine prescribing flexibilities through December 31, 2026. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. Sheppard Mullin Richter & Hampton LLP. (2025, August). Telehealth and in-person visits: Tracking federal and state updates to pandemic-era telehealth exceptions. https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/

3. Center for Connected Health Policy. (2025, November-December). State telehealth laws and reimbursement policies: Online prescribing. https://www.cchpca.org/topic/online-prescribing/

4. Health Jobs Nationwide. (2025). State-by-state guide: Expanding roles for PAs and NPs (Updated 2025). https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/

5. DailyMed, National Library of Medicine. (Latest revision). Bupropion hydrochloride extended-release tablets – FDA prescribing information. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=1b69c253-4740-44b0-be63-6c20834540b6&type=display

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=patients%20to%20receive%20prescriptions%20for,while%20permanent%20rules%20are%20finalized
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=extended%20telemedicine%20prescribing%20waivers%20through,prescribing
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=Full%20practice%20authority%20legislation%20reached,12
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=coordination%20with%20the%20U,prescribing
• https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth#:~:text=The%20Drug%20Enforcement%20Administration%20,through%20December%2031%2C%202025
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Prior%20to%20the%202024%20waiver,access%2C%20and%20diversion%20control%20measures
• https://www.cchpca.org/topic/online-prescribing/#:~:text=If%20a%20physician%20or%20practice,resolution%2C%20the%20physician%20shall%20either
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=constitutes%20unprofessional%20conduct,the%20appropriate%20standard%20of%20care
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=California%20leads%20the%20most%20important,12